FDA-Rejected Prescription Drugs


	Prescription Drugs Rejected by the FDA
	This page lists selected prescription drugs that were rejected for approval by the FDA. The drugs are listed by rejection date. The Rejection Date is very useful for searching for additional information about the drug.		*Vaughn's Summaries* *Medical Summaries* Prescription Drug Classes Prescription Drug Lawsuits Prescription Drug Painkillers Prescription Drug Risks Prescription Drug Sales Prescription Drug Side Effects Prescription Drug TV Ads Prescription Drug Warnings Rejected Prescription Drugs Unapproved Prescription Drugs
30	540-860	30	260

. Disapproved Prescription Drugs Chart New Drugs that Have Been Voted Down by the FDA
	Brand Name (generic name)	Date Rejected	Reason for Rejection	Manufacturer	Condition Targetted	-
	2010
	Lorqess lorcaserin	Oct. 24, 2010	Causes cancer in rats Efficacy highly questioned	Arena Pharma.	obesity	-
	JZP-6 sodium oxybate	Oct, 12, 2010	the "date-rape" drug Previously sold as Xyrem in 2002	Jazz Pharma.	fibromyalgia pain killer	-
	Qnexa phentermine + topiramate	Jul. 16, 2010	Heart rate, birth defects, psychiatric problems	Vivus, Inc.	obesity	-
	Daxas roflumilast	May 17, 2010	modest benefit, high risk suicide and weight loss	Forest Labs	chronic COPD	-
	Naproxcinod nitronaproxen	May 12, 2010	insufficient data	NicOx	arthritis	-
	Pirespa pirfenidone	May 4, 2010	additional trials required	Intermune	idiopathic pulmonary fibrosis (IPF)	-
	Acurox (oxycodone + niacin)	Apr. 22, 2010	side effects, unproven advantage	Acura/ King	painkiller	-
	Afinitor everolimus	Feb. 9 2010	cost (NHS rejection)	Novartis	kidney cancer	-
	2009
	Zeftera ceftobiprole	Dec. 30 2009	unreliable data	J & J	skin infection	-
	Lyrica pregabalin	Dec. 25 2009	insufficient evidence to approve (later approved)	Pfizer	anxiety	-
	Silenor doxepin	Dec. 7 2009	not effective	Somaxon	insomnia	-
	Lumizyme alglucosidase alfa	Nov. 16 2009	manufacturing process	Genzyme	Pompe disease	-
	Krystexxa pegloticase	Aug. 5 2009	manufacturing process	Savient	gout	-
	2008
	Remoxy oxycodone	Dec. 11 2008	further data required	King Pharma.	painkiller	-
	Oritavancin oritavancin	Dec. 10 2008	not shown to be safe or effective	Targanta	skin infection	-
	Xxxx iclaprim	Nov. 20 2008	not shown to be safe or effective	Arpida	antibiotic	-
	Cayston aztreonam lysine	Sept. 17 2008	lack of data	Gilead	cystic fibrosis	-
	Bridion sugammadex	Aug. 1 2008	concern agout hypersensitivity and allergic reactions	Schering-Plough	anesthesia	-
	Fanapt iloperidone	July 28 2008	more testing needed	Vanda	schizophrenia	-
	Cipro ciprofloxacin	July 8 2008	tendonitis and tendon rupture (new strong warnings required)	Bayer	antibiotic	-
	Cordaptive MK-0524A	Apr. 26 2008	lack of information (Tredaptive (in the US)	Merck	cholesterol	-
	Zyprexa olanzipine	Feb. 28 2008	rejected long-lasting injectable form "not approvable"	Lilly	schizophrenia	-
	2007
	Velexity gepirone ER	Nov. 3 2007	high risk, bad history	GSK	antidepressant	-
	Frova frovatriptan succinate	Oct. 2 2007	long-term safety	Vernalis	menstrual migraine	-
	2000
	Foscan temoporfin	Sept. 26, 2000	rejection reason is unclear meta-tetrahydroxy-phenylchlorin	Scotia Holdings	head and neck cancer	-
top of page
20	150	80	260-770	130	130
. Drug Side Effects . . . . . Medical Malpractice Attorneys . . . . . Prescription Drug Risks

Tags: failed drugs, disapproved prescription drugs, FDA drug failures

Disclaimer
The author is not a doctor.
NO MEDICAL ADVICE IS OFFERED OR IMPLIED.
Statements on this page may NOT be correct.
These are just my personal thoughts.
The sole purpose of this page is to encourage further research on your part.

I hope that you have found this prescription drug lawsuit page helpful.
Thank you very much for your time.

"placed on clinical hold"
"sends warning letter"
"false or misleading"
"promotional material misleading"
"FDA rejected"
"FDA demands more data"
"FDA decision delayed"
"FDA has issues"
"FDA raised safety concerns"
"FDA warns of severe pain"

top of page

This Vaughns FDA-Rejected Prescription Drugs list web page was last updated on 2011-03-10.